by Lolita Tsanaclis
on May 15, 2019
Data published by the National Programme on Substance Abuse Deaths (NPSAD) has highlighted the increase in drug related deaths due to the use of ‘legal highs’ commonly referred to as Novel Psychoactive Substances (NPS).
The presence of Novel Psychoactive Substances (NPS) in toxicology tests performed for post mortem examinations indicated the prevalence of NPS has increased 800% over three years (2009 – 2012).
Cansford Laboratories presented the increasing incidence of one NPS, Mephedrone (Meow Meow) use at the Society of Hair Testing in Toronto during 2012. Previously, we reported an increase in the number of samples testing positive for Mephedrone.
From Cansford laboratory’s data, we are noticing an increasing number of samples testing positive for Amphetamines, with Mephedrone still being positive in around 10% of samples which are analysed for the drug.
Subscribe to Email Updates
Recent Posts
Posts by Topic
- Hair drug testing (41)
- Workplace Drug Testing (38)
- Drug and alcohol testing (20)
- Family Court (18)
- Drug testing (12)
- Cansford Laboratories (10)
- Drug test results (10)
- hair strand drug testing (8)
- Hair Collection (7)
- Alcohol testing (6)
- In the press... (6)
- SoHT (6)
- COVID-19 (4)
- Laboratory accreditation (4)
- News (4)
- Chain of Custody (3)
- Did you know? (3)
- Drug and DNA testing (3)
- Frequently Asked Questions (3)
- New psychoactive substances (3)
- Steroid Testing (3)
- hair (3)
- Drug test costs (2)
- Resources (2)
- drug testing in sport (2)
- ethics of hair testing (2)
- Accreditation (1)
- Brexit (1)
- Expert witness (1)
- Oral fluid testing (1)
- Scientific Presentations (1)
- social workers (1)
- vulnerable children (1)